Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Ironwood Pharmaceuticals Company Profile (NASDAQ:IRWD)

Consensus Ratings for Ironwood Pharmaceuticals (NASDAQ:IRWD) (?)
Ratings Breakdown: 6 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $17.00 (12.55% upside)

Current Analysts' Coverage Summary for Ironwood Pharmaceuticals (NASDAQ:IRWD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/11/2015ZacksReiterated RatingNeutral -> Neutral$16.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2015Cantor FitzgeraldReiterated RatingHold$13.50ViewTweet This Rating  Share This Rating on StockTwits
3/3/2015BarclaysInitiated CoverageEqual Weight$18.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2015WallachBeth CapitalBoost Price TargetHold$15.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
2/9/2015JPMorgan Chase & Co.Boost Price TargetOverweight$20.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Cowen and CompanyDowngradeOutperform -> Market Perform$16.00 -> $10.50ViewTweet This Rating  Share This Rating on StockTwits
8/5/2014Leerink SwannReiterated RatingMarket Perform$15.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
7/9/2014Furey Research PartnersInitiated CoverageBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014MizuhoBoost Price TargetBuy$17.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
4/29/2014AegisReiterated RatingBuy -> PositiveViewTweet This Rating  Share This Rating on StockTwits
4/23/2014Bank of AmericaUpgradeBuyViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BMO Capital MarketsUpgradeMarket Perform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
10/24/2013Jefferies GroupLower Price TargetHold$12.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2013WedbushLower Price TargetNeutral$12.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
9/17/2013Goldman SachsInitiated CoverageSellViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Janney Montgomery ScottUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
6/21/2013Credit Suisse Group AGInitiated CoverageOutperform$16.00 -> $11.31ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/26/2013 forward)